1.
Menter A, Boh E, Lewitt G, Jacobson A. Efficacy of Brodalumab vs Ustekinumab by Prior TNF╬▒ Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.11];5(6):s51. Available from: https://www.jofskin.org/index.php/skin/article/view/1402